Skip to main content

Southern Research Institute Inks Drug Target Collaboration with Genome Explorations

NEW YORK, Oct. 27 (GenomeWeb News) - Southern Research Institute and Genome Explorations said today that they have agreed to collaborate on the identification of drug targets using gene expression profiling.

 

The partners said that the effort would join Genome Explorations' microarray genetics testing and analysis technology with Southern Research Institute's drug discovery and development expertise. Genome Explorations and Southern Research Institute also said they intend to co-market individual and combined services.

 

Additional terms of the arrangement were not disclosed.

 

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.